2 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems (EE-ASI)
Date du début: 1 sept. 2012, Date de fin: 31 mai 2017,
Current approaches to improving glycaemic control in type 1 diabetes are centered on increasingly complex insulin delivery systems. However, less than 30% of patients can achieve target levels of glucose control with this approach even in a clinical trial setting and many patients are either unable or unwilling to make the personal commitment required. By contrast, preservation of even sma ...
Voir le projet
8
Participants partenaires
TERMINÉ
Beta Cell Therapy in Diabetes (BETACELLTHERAPY)
Date du début: 1 janv. 2010, Date de fin: 30 juin 2015,
Type 1 diabetes is a serious chronic disease with major health risks and heavy burden on patients and society. It is caused by massive immune-mediated loss of insulin-producing beta cells in the pancreas that can so far not be locally corrected. A cellular allotransplant in the liver can install a new beta cell mass but the size is insufficient and the procedure faces limitations of donor shortage ...
Voir le projet